Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 76.43M | 3.86 | $ 19.8M |
3/31/2025 | $ 71.79M | 3.89 | $ 18.43M |
12/31/2024 | $ 105.16M | 2.66 | $ 39.48M |
9/30/2024 | $ 82M | 1.16 | $ 70.6M |
6/30/2024 | $ 189.2M | 2.2 | $ 85.81M |
3/31/2024 | $ 72.39M | 0.42 | $ 173.94M |
12/31/2023 | $ 71.55M | 0.45 | $ 158.8M |
9/30/2023 | $ 55.83M | 0.34 | $ 165.43M |
6/30/2023 | $ 83.69M | 0.66 | $ 125.94M |
3/31/2023 | $ 231.6M | 1.57 | $ 147.59M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ENTRADA THERAPEUTICS INC is calculated as follows: CashnEq [ $ 39.05M ] / LiabilitesC [ $ 3.36M ]
(=) Cash Ratio [ 11.62 ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |